Irfan Qureshi, MD
Surgical Critical Care · Pine Bluff, ARNPI 1881853133
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (41.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Davol Inc. at 41.3% of the total. Reporting peaked in 2019 at $712 and has fallen 71.6% since, to $202 in 2024.
Across 23 payments — averaging $70.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$675
- Medical Device Business Services, Inc.$305
- Smith+Nephew$269
- Abiomed$125
- Novo Nordisk$58
- Pacira Pharmaceuticals Incorporated$43
- plus $157 from 7 others
What the payments were for
- Travel & lodging$67541%
- Food & beverage$63939%
- Education$31820%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 2 | $675 |
| Medical Device Business Services, Inc. | 1 | $305 |
| Smith+Nephew | 5 | $269 |
| Abiomed | 1 | $125 |
| Novo Nordisk | 4 | $58 |
| Pacira Pharmaceuticals Incorporated | 1 | $43 |
| KCI USA, Inc. | 2 | $37 |
| Johnson & Johnson | 2 | $32 |
| Convatec Inc. | 1 | $22 |
| Amgen | 1 | $21 |
| Medline Industries LP | 1 | $18 |
| Medtronic | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few surgical critical care providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 43 | $784 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 24 | $414 |
| Oxycodone Hcl | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Other surgical critical care in Pine Bluff
- Leigh RobinsonPine Bluff$3K
- Matthew RobertsLittle Rock$8K
- Nolan BruceLittle Rock$5K
- Joseph MargolickLittle Rock$4K
- Esther TeoLittle Rock$2K
- Melissa KostLittle Rock$1K
- Richard YeagerLittle Rock$330
- Robert VandewalleLittle Rock$215
- Richard BetzoldLittle Rock$181
- Mary KimbroughLittle Rock$72
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.